Manifestations of hypersensitivity to anti-tuberculosis drugs Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018
Rifamycin induced leukocytoclastic vasculitis. A rare side-effect of anti-tuberculous chemotherapy Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Pneumopathy to thalidomide Source: Eur Respir J 2006; 28: Suppl. 50, 96s Year: 2006
Hepatotoxicity due to antituberculosis drug treatment Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II Year: 2008
Development of Addisonian crisis during the antituberculosis treatment associated with hypopituitarism Source: Eur Respir J 2004; 24: Suppl. 48, 201s Year: 2004
Incidence and timing of hepatotoxicity due to anti-tuberculous treatment Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011
Response of pulmonary tuberculoma to anti-tuberculosis treatment Source: Eur Respir J 2003; 22: Suppl. 45, 521s Year: 2003
Etiology and etiotropic therapy of angiogenic sepsis Source: Eur Respir J 2003; 22: Suppl. 45, 452s Year: 2003
Unusual presentation of pulmonary nocardiosis as pyopneumothorax in a patient under corticotherapy Source: International Congress 2019 – Interstitial lung diseases? Year: 2019
Antituberculotic drug-induced medicamentous liver damages Source: Eur Respir J 2004; 24: Suppl. 48, 51s Year: 2004
Unusual multisystemic relapse of sarcoidosis after corticosteroids withdrawal Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013
Evaluation of antituberculous drugs administration Source: Eur Respir J 2002; 20: Suppl. 38, 547s Year: 2002
Fulminant hepatitis during antituberculosis chemotherapy: five case reports Source: Eur Respir J 2005; 26: Suppl. 49, 645s Year: 2005
Monitoring of antituberculous drugs adverse events during the treatment of multidrug-resistant pulmonary tuberculosis Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011
Predictors of hepatotoxicity among patients with tuberculosis treated with antituberculous medication Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Fringe manifestations in sarcoidosis and side effects of corticotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 543s Year: 2006
Efficacy of intravenous administration of anti-tuberculosis drugs in patients with multidrug-resistant tuberculosis Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Pleuropulmonary manifestations disclosing hepatic amebiasis Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009
Immuno-allergic reactions to antituberculosis treatment Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013
Two-coloured magnetic-laser therapy in sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005